Target Poor or Non Binder(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T89988 | Target Info | |||
Target Name | C-C chemokine receptor type 2 (CCR2) | ||||
Synonyms |
Monocyte chemoattractant protein 1 receptor; MCP-1-R; Chemokine receptor CCR2B; CMKBR2; CD192; CCR-2; CC-CKR-2; C-C CKR-2
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | CCR2 | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Poor Binders of This Target (in total, 17 binders) | Download | Top | |||
---|---|---|---|---|---|
Compound Name |
N-[[1-[(4-Chlorophenyl)methyl]piperidin-4-yl]methyl]-5-oxo-5-phenylpentanamide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL184220; BDBM50153957; 5-Oxo-5-phenyl-pentanoic acid [1-(4-chloro-benzyl)-piperidin-4-ylmethyl]-amide
Click to Show/Hide
|
||||
Activity |
IC50 = 50000 nM
|
[1] | |||
Compound Name |
1-Biphenyl-4-ylmethyl-1H-indole-2-carboxylic acid
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL132719; BDBM50138360
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[2] | |||
Compound Name |
[2-[Methyl(oxan-4-yl)amino]-2,3,4,5,6,6a-hexahydro-1H-pentalen-3a-yl]-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]methanone
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
US8906911, Compound A; CHEMBL3650411; SCHEMBL12434399; BDBM140258
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[3] | |||
Compound Name |
11-Butyl-3-[1-(4,6-dimethylpyrimidine-5-carbonyl)-4-methyl-4-piperidyl]-9-[(4-ethoxycyclohexyl)methyl]-3,9-diazaspiro[5.5]undecan-10-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL449621; SCHEMBL3963928; BDBM50254750
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[4] | |||
Compound Name |
PharmaGSID_48521
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL1078231; DSSTox_CID_28495; DSSTox_RID_82770; DSSTox_GSID_48521; DTXSID8048521; SCHEMBL18841093; Tox21_303454; BDBM50310739; NCGC00257432-01
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[5] | |||
Compound Name |
1-(4-Benzyloxy-benzyl)-5-chloro-1H-indole-2-carboxylic acid
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL335894; BDBM50138334
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[2] | |||
Compound Name |
1-(3,4-Dichloro-benzoyl)-1H-indole-2-carboxylic acid
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL338782; BDBM50138342
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[2] | |||
Compound Name |
N-(2-{[1-(4-Chloro-benzyl)-piperidin-4-ylmethyl]-carbamoyl}-ethyl)-benzamide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL185190; BDBM50153956
Click to Show/Hide
|
||||
Activity |
IC50 = 64000 nM
|
[1] | |||
Compound Name |
N-({[1-(4-Chloro-benzyl)-pyrrolidin-2-ylmethyl]-carbamoyl}-methyl)-benzamide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL184474; BDBM50153947; Benzamide, N-[2-[[[1-[(4-chlorophenyl)methyl]-2-pyrrolidinyl]methyl]amino]-2-oxoethyl]-; N-[2-[[1-[(4-chlorophenyl)methyl]pyrrolidin-2-yl]methylamino]-2-oxo-ethyl]benzamide
Click to Show/Hide
|
||||
Activity |
IC50 = 66000 nM
|
[1] | |||
Compound Name |
N-{2-[1-(4-Chloro-benzyl)-piperidin-3-ylcarbamoyl]-ethyl}-benzamide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL364405; BDBM50153953
Click to Show/Hide
|
||||
Activity |
IC50 = 74000 nM
|
[1] | |||
Compound Name |
5-Oxo-5-phenyl-pentanoic acid [1-(4-chloro-benzyl)-piperidin-3-yl]-amide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL363994; BDBM50153961
Click to Show/Hide
|
||||
Activity |
IC50 = 87000 nM
|
[1] | |||
Compound Name |
1-(2,4-Dichlorobenzyl)-3-(1H-indazol-5-yl)urea
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL224887; SCHEMBL5639644; BDBM50196709; N-(2,4-dichlorobenzyl)-N0-(1H-5-indazolyl)urea; 1-[(2,4-dichlorophenyl)methyl]-3-(1H-indazol-5-yl)urea
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[6] | |||
Compound Name |
1-(2,6-Dichlorobenzyl)-3-(1H-indazol-5-yl)urea
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL225224; SCHEMBL5640848; BDBM50196687; 1-(2,6-dichlorophenyl)-3-(3H-indazol-5-yl)urea; 1-[(2,6-dichlorophenyl)methyl]-3-(1H-indazol-5-yl)urea
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[6] | |||
Compound Name |
N1-(1-Benzyl-4-piperidyl)-N1-(1H-5-indazolyl)acetamide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL427103; SCHEMBL5640590; BDBM50196714; N-(1-benzylpiperidin-4-yl)-N-(1H-indazol-5-yl)acetamide
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[6] | |||
Compound Name |
1-Benzyl-3-(1H-indazol-5-yl)urea
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL225282; SCHEMBL5643084; N-benzyl-N0-(1H-5-indazolyl)urea; BDBM50196697
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[6] | |||
Compound Name |
1-(4-Chloro-benzyl)-4-(4-methanesulfonyl-benzyl)-[1,4]diazepane
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL184304; BDBM50153914
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
1-(2,6-Difluorobenzyl)-3-(1H-indazol-5-yl)urea
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL225560; SCHEMBL5639658; BDBM50196681; N-(2,6-difluorobenzyl)-N0-(1H-5-indazolyl)urea; 1-[(2,6-difluorophenyl)methyl]-3-(1H-indazol-5-yl)urea
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[6] | |||
Click to Show/Hide the Information of All Poor Binders |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5413-6. | ||||
REF 2 | N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptor. Bioorg Med Chem Lett. 2004 Jan 19;14(2):405-8. | ||||
REF 3 | US patent application no. 8906911B2, Chemokine receptor antagonists | ||||
REF 4 | Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonist. Bioorg Med Chem Lett. 2009 Jan 1;19(1):209-13. | ||||
REF 5 | Spiropiperidine CCR5 antagonists. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5401-6. | ||||
REF 6 | Design and synthesis of Rho kinase inhibitors (II). Bioorg Med Chem. 2007 Jan 1;15(1):350-64. | ||||
REF 7 | Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5407-11. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.